- Trials Expand Evidence for Hypertrophic Cardiomyopathy Tx Medscape
- Mavacamten No Match for Nonobstructive HCM in Phase III Trial MedPage Today
- MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide TCTMD.com
- Will Camzyos Strengthen BMY’s Cardiovascular Portfolio? Yahoo Finance
- Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025 BioSpace